• Study on the Safety and Effects of Sebetralstat for Children Aged 2-11 with Hereditary Angioedema Type I or II

    Not recruiting

    3 1 1
    Investigated Drugs:
    France Germany Italy
  • Study of tiratricol treatment in children with MCT8 deficiency (Monocarboxylate Transporter 8 deficiency) to improve motor development

    Not recruiting

    2 1 1
    Investigated Drugs:
    Czechia The Netherlands
  • Study on Nivolumab, Ipilimumab, and Bevacizumab for Patients with Non-Small Cell Lung Cancer Spread to the Brain

    Not recruiting

    2 1 1 1
    Germany
  • Study on the Effectiveness and Safety of a Vaccine with Dendritic Cells for Patients with Newly Diagnosed Glioblastoma

    Not recruiting

    2 1 1
    Germany
  • Study on Pirfenidone Inhalation Solution for Patients with Progressive Fibrosing Interstitial Lung Diseases, Including Idiopathic Pulmonary Fibrosis

    Not recruiting

    2 1 1
    Investigated Drugs:
    Czechia The Netherlands Poland
  • Study on the Safety and Efficacy of RO7204239 and Risdiplam for Patients with Spinal Muscular Atrophy

    Not recruiting

    4 1 1
    Investigated Diseases:
    Belgium Croatia France Germany Italy The Netherlands +3
  • Study on Durvalumab and Chemotherapy for Patients with Resectable Stage III Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    Germany
  • Study Comparing the Effects and Safety of FYB206 and Pembrolizumab with Chemotherapy in Patients with Metastatic Non-Squamous Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Poland Romania
  • Study on the Effectiveness and Safety of Secukinumab for Patients with New-Onset Giant Cell Arteritis in Clinical Remission

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study on the Effects of TAK-881 and Hyaluronidase in Adults with Primary Immunodeficiency Diseases

    Not recruiting

    4 1 1 1
    Czechia Denmark Germany Greece The Netherlands Poland +2

powered by